首页> 外文期刊>Experimental Neurology >Gastrin-releasing peptide facilitates glutamatergic transmission in the hippocampus and effectively prevents vascular dementia induced cognitive and synaptic plasticity deficits
【24h】

Gastrin-releasing peptide facilitates glutamatergic transmission in the hippocampus and effectively prevents vascular dementia induced cognitive and synaptic plasticity deficits

机译:胃泌素释放肽有助于海马中的谷氨酸糖醛透过,有效地防止血管痴呆诱导的认知和突触塑性缺陷

获取原文
获取原文并翻译 | 示例
       

摘要

Neuronal gastrin-releasing peptide (GRP) has been proved to be an important neuromodulator in the brain and involved in a variety of neurological diseases. Whether GRP could attenuate cognition impairment induced by vascular dementia (VD) in rats, and the mechanism of synaptic plasticity and GRP's action on synaptic efficiency are still poorly understood. In this study, we first investigated the effects of GRP on glutamatergic transmission with patch-clamp recording. We found that acute application of GRP enhanced the excitatory synaptic transmission in hippocampal CA1 neurons via GRPR in a presynaptic mechanism. Secondly, we examined whether exogenous GRP or its analogue neuromedin B (NMB) could prevent VD-induced cognitive deficits and the mechanism of synaptic plasticity. By using Morris water maze, long-term potentiation (LTP) recording, western blot assay and immunofluorescent staining, we verified for the first time that GRP or NMB substantially improved the spatial teaming and memory abilities in VD rats, restored the impaired synaptic plasticity and was able to elevate the expression of synaptic proteins, synaptophysin (SYP) and CaMKII, which play pivotal roles in synaptic plasticity. These results suggest that the facilitatory effects of GRP on glutamate release may contribute to its long-term action on synaptic efficacy which is essential in cognitive function. Our findings present a new entry point for a better understanding of physiological function of GRP and raise the possibility that GRPR agonists might ameliorate cognitive deficits associated with neurological diseases. (C) 2016 Elsevier Inc. All rights reserved.
机译:被证明是神经元胃泌素释放肽(GRP)是大脑中的重要神经调节剂,并参与各种神经疾病。 GRP是否可以衰减由大鼠血管痴呆(VD)诱导的认知损伤,并且突触塑性和GRP对突触效率的作用的机制仍然不知所决。在这项研究中,我们首先研究了GRP对带有贴片夹具的谷氨酰胺透射的影响。我们发现GRP的急性应用通过GRPR在突触前机制中增强了海马CA1神经元的兴奋性突触传递。其次,我们检查了外源GRP或其类似物神经细胞B(NMB)是否可以防止VD诱导的认知缺陷和突触可塑性的机制。通过使用Morris水迷宫,长期增强(LTP)记录,Western印迹测定和免疫荧光染色,我们首次验证了GRP或NMB的第一次基本上改善了VD大鼠的空间组合和记忆能力,恢复了突触可塑性受损和能够升高突触蛋白,突触蛋白(SYP)和Camkii的表达,其在突触可塑性中起着枢转作用。这些结果表明,GRP对谷氨酸释放的促进作用可能导致其对突触疗效的长期作用,这在认知功能中至关重要。我们的研究结果提出了一种更好地理解GRP的生理功能,并提高GRPR激动剂可能改善与神经疾病相关的认知缺陷的可能性。 (c)2016年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号